Conference Coverage

Low threshold to biopsy atypical lesions may ID vulvar melanoma early, experts say

Publish date: November 16, 2020

 

FROM A CONFERENCE ON DISEASES OF THE VULVA AND VAGINA

Dr. Mauskar and Dr. Reutter had no relevant financial conflicts of interest.

jremaly@mdedge.com

Pages

Recommended Reading

Are uterine manipulators safe for gynecologic cancer surgery?
MDedge Hematology and Oncology
Cancer therapy affects sexual health in most patients
MDedge Hematology and Oncology
SRS instead of WBRT for patients with multiple brain metastases
MDedge Hematology and Oncology
A guide to the new agents reshaping ovarian cancer treatment
MDedge Hematology and Oncology
New technologies aim to improve ovarian cancer detection
MDedge Hematology and Oncology
IMRT new standard of care for high-risk cervical cancer
MDedge Hematology and Oncology
One-month delay in cancer treatment linked to increase in mortality
MDedge Hematology and Oncology
Rare event: Iatrogenic injury during cervical cancer screening
MDedge Hematology and Oncology
New cancer drugs may have saved more than 1.2 million Americans
MDedge Hematology and Oncology
‘Test all patients with cancer’: One in eight have inherited mutations
MDedge Hematology and Oncology